首页> 外文期刊>Cellular and molecular life sciences: CMLS >Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs
【24h】

Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs

机译:根除受感染患者的艾滋病毒的策略:消除潜伏的潜航水库

获取原文
获取原文并翻译 | 示例
           

摘要

35 years since identification of HIV as the causative agent of AIDS, and 35 million deaths associated with this disease, significant effort is now directed towards the development of potential cures. Current anti-retroviral (ART) therapies for HIV/AIDS can suppress virus replication to undetectable levels, and infected individuals can live symptom free so long as treatment is maintained. However, removal of therapy allows rapid re-emergence of virus from a highly stable reservoir of latently infected cells that exist as a barrier to elimination of the infection with current ART. Prospects of a cure for HIV infection are significantly encouraged by two serendipitous cases where individuals have entered remission following stem cell transplantation from compatible HIV-resistant donors. However, development of a routine cure that could become available to millions of infected individuals will require a means of specifically purging cells harboring latent HIV, preventing replication of latent provirus, or destruction of provirus genomes by gene editing. Elimination of latently infected cells will require a means of exposing this population, which may involve identification of a natural specific biomarker or therapeutic intervention to force their exposure by reactivation of virus expression. Accordingly, the proposed "Shock and Kill" strategy involves treatment with latency-reversing agents (LRA) to induce HIV provirus expression thus exposing these cells to killing by cellular immunity or apoptosis. Current efforts to enable this strategy are directed at developing improved combinations of LRA to produce broad and robust induction of HIV provirus and enhancing the elimination of cells where replication has been reactivated by targeted immune modulation. Alternative strategies may involve preventing re-emergence virus from latently infected cells by "Lock and Block" intervention, where transcription of provirus is inhibited to prevent virus spread or disruption of the H
机译:35年来,自鉴定艾滋病毒作为艾滋病的致病剂,3500万人死亡与这种疾病相关的死亡,现在正在努力发展潜在治疗的发展。目前的抗逆转录病毒(ART)艾滋病毒/艾滋病的疗法可以抑制病毒复制对未定例的水平,并且感染的个体可以在维持治疗的情况下自由存在症状。然而,去除治疗允许从潜伏的细胞的高度稳定的储层快速重新出现病毒,这些细胞作为消除目前艺术的感染的障碍存在。两种偶然病例,艾滋病毒感染治愈的前景受到两种偶然的病例,其中个体在与相容的艾滋病毒抗性供体中的干细胞移植后进入缓解。然而,可以变成数百万受感染的个体的常规治疗的常规治疗将需要一种特异性吹扫细胞的方法,这些细胞涉及潜在的艾滋病毒,防止潜伏的潜伏期的复制,或通过基因编辑破坏潜伏药基因组。消除潜伏的细胞将需要一种暴露该群体的方法,这可能涉及鉴定天然特异性生物标志物或治疗干预,以通过再激活病毒表达来迫使其暴露。因此,所提出的“休克和杀死”策略涉及用潜伏期逆转剂(LRA)治疗诱导艾滋病毒潜灵术表达,从而将这些细胞暴露于通过细胞免疫或凋亡杀死。目前启用该策略的努力旨在开发LRRA的改进组合,以产生艾滋病毒潜意识的广泛和稳健诱导,增强通过靶向免疫调节重新激活复制的细胞的消除。替代策略可能涉及通过“锁定”干预来预防潜伏的细胞从潜伏的细胞中的重新出现病毒,其中潜水员的转录被抑制以防止病毒传播或破坏H.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号